Seeing Is Believing
Currently, out of the existing stock ratings of Ami Fadia - 185 which are a Buy (86.05%), 25 which are a Hold (11.63%), 5 which are a Sell (2.33%)
Analyst Ami Fadia works at NEEDHAM and is covering the Healthcare sector with 431 price targets and ratings displayed on 30 stocks. Previously, Ami Fadia worked at LEERINK.
Ami Fadia's average stock forecast success ratio is 43.59% with an average time for price targets to be met of 116.1 days.
Most recent stock forecast was given on AVDL, Avadel Pharmaceuticals plc at 25-Sep-2023.
Analyst best performing recommendations are on MNK.
The best stock recommendation documented was for SGEN (SEATTLE GENETICS) at 2/23/2023. The price target of $178 was fulfilled within 4 days with a profit of $15.81 (9.75%) receiving and performance score of 24.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Sell
1
$0.08 (8.70%)
5
2 months 8 days ago
8/9 (88.89%)
$0.6 (18.39%)
57
Buy
3
$2.08 (226.09%)
5
8 months 22 days ago
4/16 (25%)
$8.22 (56.00%)
71
Sell
1 years 3 months 22 days ago
2/4 (50%)
$4.78 (37.42%)
1444
Hold
19
$18.08 (1965.22%)
19
1 years 10 months 25 days ago
0/23 (0%)
$14.53 (233.04%)
Buy
16
$15.08 (1639.13%)
12
2 years 7 months 27 days ago
0/6 (0%)
$6.74 (91.65%)
Which stock is Ami Fadia is most bullish on?
Which stock is Ami Fadia is most reserved on?
What Year was the first public recommendation made by Ami Fadia?